Cellectis S.A. current report, Q4 FY2021

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer, on December 7, 2021. The report serves as a management update regarding corporate governance and executive leadership changes.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on personnel changes rather than financial performance.

Material Changes

  • Executive Departure: Eric Dutang resigned from his position as Chief Financial Officer (CFO). His departure was accelerated and became effective on December 2, 2021.
  • Interim Leadership: Valérie Cros, Senior Director of Accounting and Internal Controls, has been appointed as the acting principal financial officer and principal accounting officer.
  • Search Status: The Company has initiated a search to identify a permanent successor for the CFO role.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, outlook, or specific risk factors beyond the operational impact of the CFO transition. No unusual items or contingencies were disclosed in this report.

Key Facts for Investor Verification

  • Confirm the timeline for the appointment of a permanent Chief Financial Officer.
  • Review subsequent filings for any impact of the CFO transition on financial reporting or internal controls.
  • Verify the Company's cash position and liquidity status in the most recent audited financial statements, as this filing does not contain updated financial data.